FindTrial
Sign In

A study to assess whether the homoeopathic medicine Cyclamen europaeum reduces acute pain during migraine with aura and improves daily life in people with migraine.

To assess the effectiveness of cyclamen europaeum as an apsoric remedy for the management of acute pain in migraine with aura and in improving quality of life - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/07/113813
Enrollment
28
Registered
2026-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G431- Migraine with aura

Interventions

Intervention1: Nil: Nil

Sponsors

Father Muller Research Committee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients coming with migraine with aura symptoms

Exclusion criteria

Exclusion criteria: 1. Participants with condition such as cluster headaches tension headaches 2. Patients with underlying neurological conditions eg seizure stroke neurodegenerative diseases

Design outcomes

Primary

MeasureTime frame
Reduction in intensity of pain according to VAS pain scaleTimepoint: Decrease in pain after 1 month of treatment—

Secondary

MeasureTime frame
Improvement in quality of life according to Migraine specific quality of life questionnaireTimepoint: Improvement in quality of life after 1 month of treatment—

Countries

India

Contacts

Public ContactDr. Sebastian P. A.

Father Muller Homoeopathic Medical College and Hospital

drsebastianpa@gmail.com9900414393

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026